| Q46812843 | Acute effects of various antibiotic combinations on acetoclastic methanogenic activity |
| Q43360123 | Advanced treatment of municipal secondary effluent by catalytic ozonation using Fe3O4-CeO2/MWCNTs as efficient catalyst |
| Q37790100 | Advances in on-line drinking water quality monitoring and early warning systems |
| Q34195271 | An update on the strategies in multicomponent activity monitoring within the phytopharmaceutical field |
| Q57900442 | Antibiotics as CECs: An Overview of the Hazards Posed by Antibiotics and Antibiotic Resistance |
| Q46496592 | Assessment of the health risks related to the presence of drug residues in water for human consumption: application to carbamazepine |
| Q55266583 | Biological Removal of the Mixed Pharmaceuticals: Diclofenac, Ibuprofen, and Sulfamethoxazole Using a Bacterial Consortium. |
| Q43340973 | Biological removal of pharmaceuticals and personal care products during laboratory soil aquifer treatment simulation with different primary substrate concentrations |
| Q35204855 | Capability of the natural microbial community in a river water ecosystem to degrade the drug naproxen. |
| Q39512563 | Chronic and low exposure to a pharmaceutical cocktail induces mitochondrial dysfunction in liver and hyperglycemia: Differential responses between lean and obese mice |
| Q36922660 | Consumer-perceived risks and choices about pharmaceuticals in the environment: a cross-sectional study |
| Q40095970 | Development of a UPLC-MS/MS method for the determination of ten anticancer drugs in hospital and urban wastewaters, and its application for the screening of human metabolites assisted by information-dependent acquisition tool (IDA) in sewage samples |
| Q43337388 | Direct UV photolysis of selected pharmaceuticals, personal care products and endocrine disruptors in aqueous solution |
| Q38979288 | Do pharmaceuticals reach and affect the aquatic ecosystems in Brazil? A critical review of current studies in a developing country. |
| Q46300466 | Ecotoxicological risk assessment of chosen pharmaceuticals detected in surface waters |
| Q61977152 | Electro-Fenton degradation of the antibiotic sulfanilamide with Pt/carbon-felt and BDD/carbon-felt cells. Kinetics, reaction intermediates, and toxicity assessment |
| Q43354106 | Electrochemical incineration of omeprazole in neutral aqueous medium using a platinum or boron-doped diamond anode: degradation kinetics and oxidation products |
| Q90686697 | Estimating the transport parameters of propyphenazone, caffeine and carbamazepine by means of a tracer experiment in a coarse-gravel unsaturated zone |
| Q50858244 | Fate of selected drugs in the wastewater treatment plants (WWTPs) for domestic sewage. |
| Q28831097 | Hidden drivers of low-dose pharmaceutical pollutant mixtures revealed by the novel GSA-QHTS screening method |
| Q43163512 | Human health risk assessment of pharmaceuticals in water: an uncertainty analysis for meprobamate, carbamazepine, and phenytoin |
| Q24631727 | Human health risk assessment of pharmaceuticals in water: issues and challenges ahead |
| Q47725120 | Impact of inoculum sources on biotransformation of pharmaceuticals and personal care products. |
| Q43350313 | Industrial-scale application of the plunger flow electro-oxidation reactor in wastewater depth treatment. |
| Q38140119 | Is biological treatment a viable alternative for micropollutant removal in drinking water treatment processes? |
| Q38377113 | Life cycle assessment and costing of urine source separation: Focus on nonsteroidal anti-inflammatory drug removal |
| Q43340588 | Mineralization of flumequine in acidic medium by electro-Fenton and photoelectro-Fenton processes |
| Q46306825 | Nitrate and carbon matter removals from real effluents using Si/BDD electrode. |
| Q37628830 | Occurrence of Emerging Micropollutants in Water Systems in Gauteng, Mpumalanga, and North West Provinces, South Africa. |
| Q40199955 | Occurrence of diazepam and its metabolites in wastewater and surface waters in Beijing. |
| Q43337009 | Occurrence of endocrine disrupters and selected pharmaceuticals in Aisonas River (Greece) and environmental risk assessment using hazard indexes |
| Q33764240 | Pharmaceuticals and personal care products in waters: occurrence, toxicity, and risk |
| Q48539174 | Pharmaceuticals in the environment: an educational perspective |
| Q38193126 | Potential environmental implications of nano-enabled medical applications: critical review |
| Q37098784 | Practice, awareness and opinion of pharmacists toward disposal of unwanted medications in Kuwait |
| Q57238659 | Resilience to heat waves in the aquatic snail Lymnaea stagnalis : Additive and interactive effects with micropollutants |
| Q34983685 | Review of the occurrence of anti-infectives in contaminated wastewaters and natural and drinking waters |
| Q57157856 | Risk assessment of environmental mixture effects |
| Q47410334 | Seasonal occurrence, removal and risk assessment of 10 pharmaceuticals in 2 sewage treatment plants of Guangdong, China |
| Q86443731 | Sediment-water interactions of pharmaceutical residues in the river environment |
| Q43685827 | Stability of lysosomal membrane in Carcinus maenas acts as a biomarker of exposure to pharmaceuticals |
| Q46939912 | Toxicities of four anti-neoplastic drugs and their binary mixtures tested on the green alga Pseudokirchneriella subcapitata and the cyanobacterium Synechococcus leopoliensis |
| Q39551141 | Toxicity of individual pharmaceuticals and their mixtures to Aliivibrio fischeri: Experimental results for single compounds and considerations of their mechanisms of action and potential acute effects on aquatic organisms |
| Q40119818 | Toxicity of the mixture of selected antineoplastic drugs against aquatic primary producers |
| Q47759467 | UPLC-MS/MS analysis of antibiotics in pharmaceutical effluent in Tunisia: ecotoxicological impact and multi-resistant bacteria dissemination |
| Q36318178 | Water-borne pharmaceuticals reduce phenotypic diversity and response capacity of natural phytoplankton communities |